REVERSIBLE TOXIN AND THE USE THEREOF

Details for Australian Patent Application No. 2003218702 (hide)

Owner MEDIGENE AG

Inventors HENKEL, Thomas; ROHRBACH, Martin

Pub. Number AU-A-2003218702

PCT Number PCT/EP03/02352

PCT Pub. Number WO2003/076618

Priority 102 10 285.6 08.03.02 DE

Filing date 7 March 2003

Wipo publication date 22 September 2003

International Classifications

C12N 015/10 Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 015/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 015/81 Mutation or genetic engineering - for yeasts

C07K 014/195 Peptides having more than 20 amino acids - from bacteria

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 102 10 285.6 08.03.02 DE

30 October 2003 Application Open to Public Inspection

  Published as AU-A-2003218702

25 November 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003218703-SPECIFIC AB1'-ANTIBODIES AGAINST TUMOUR-ASSOCIATED ANTIGEN CA 125

2003218701-Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release